BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 18402774)

  • 1. C-RAF activation promotes BAD poly-ubiquitylation and turn-over by the proteasome.
    Fueller J; Becker M; Sienerth AR; Fischer A; Hotz C; Galmiche A
    Biochem Biophys Res Commun; 2008 Jun; 370(4):552-6. PubMed ID: 18402774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raf-1 and B-Raf promote protein kinase C theta interaction with BAD.
    Hindley A; Kolch W
    Cell Signal; 2007 Mar; 19(3):547-55. PubMed ID: 17011751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Raf antagonizes apoptosis induced by IFN-alpha in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A.
    Lamberti A; Longo O; Marra M; Tagliaferri P; Bismuto E; Fiengo A; Viscomi C; Budillon A; Rapp UR; Wang E; Venuta S; Abbruzzese A; Arcari P; Caraglia M
    Cell Death Differ; 2007 May; 14(5):952-62. PubMed ID: 17332776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel C-Raf phosphorylation sites: serine 296 and 301 participate in Raf regulation.
    Hekman M; Fischer A; Wennogle LP; Wang YK; Campbell SL; Rapp UR
    FEBS Lett; 2005 Jan; 579(2):464-8. PubMed ID: 15642359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association.
    Jin S; Zhuo Y; Guo W; Field J
    J Biol Chem; 2005 Jul; 280(26):24698-705. PubMed ID: 15849194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel in vivo phosphorylation sites of the human proapoptotic protein BAD: pore-forming activity of BAD is regulated by phosphorylation.
    Polzien L; Baljuls A; Rennefahrt UEE; Fischer A; Schmitz W; Zahedi RP; Sickmann A; Metz R; Albert S; Benz R; Hekman M; Rapp UR
    J Biol Chem; 2009 Oct; 284(41):28004-28020. PubMed ID: 19667065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis by p110C requires mitochondrial translocation of the proapoptotic BCL-2 family member BAD.
    Chen C; Yan J; Sun Q; Yao L; Jian Y; Lu J; Gu J
    FEBS Lett; 2006 Feb; 580(3):813-21. PubMed ID: 16413544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone inhibits phosphorylation of mitogen-activated protein kinase (MAPK) ERK1/2 through inhibition of c-Raf and activation of MKP-1 in osteoblastic cells.
    Lai LP; Mitchell J
    Cell Biochem Funct; 2009 Jul; 27(5):269-75. PubMed ID: 19384851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the stability and transcriptional activity of NFATc4 by ubiquitination.
    Fan Y; Xie P; Zhang T; Zhang H; Gu D; She M; Li H
    FEBS Lett; 2008 Dec; 582(29):4008-14. PubMed ID: 19026640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of polyubiquitin chains.
    Adhikari A; Chen ZJ
    Dev Cell; 2009 Apr; 16(4):485-6. PubMed ID: 19386255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21-Activated kinase 1 (Pak1) phosphorylates BAD directly at serine 111 in vitro and indirectly through Raf-1 at serine 112.
    Ye DZ; Jin S; Zhuo Y; Field J
    PLoS One; 2011; 6(11):e27637. PubMed ID: 22096607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol prevents the injury-induced decrease of 90 ribosomal S6 kinase (p90RSK) and Bad phosphorylation.
    Koh PO
    Neurosci Lett; 2007 Jan; 412(1):68-72. PubMed ID: 17196335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calmodulin modulates H-Ras mediated Raf-1 activation.
    Moretó J; Lladó A; Vidal-Quadras M; Calvo M; Pol A; Enrich C; Tebar F
    Cell Signal; 2008 Jun; 20(6):1092-103. PubMed ID: 18356021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Wu JS; Lin TN; Wu KK
    J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
    Schmidtke G; Kalveram B; Groettrup M
    FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NBS1 is required for IGF-1 induced cellular proliferation through the Ras/Raf/MEK/ERK cascade.
    Hematulin A; Sagan D; Eckardt-Schupp F; Moertl S
    Cell Signal; 2008 Dec; 20(12):2276-85. PubMed ID: 18793719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of human enhancer of filamentation (HEF1) on serine 369 induces its proteasomal degradation.
    Hivert V; Pierre J; Raingeaud J
    Biochem Pharmacol; 2009 Oct; 78(8):1017-25. PubMed ID: 19539609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death.
    Kewalramani G; Puthanveetil P; Wang F; Kim MS; Deppe S; Abrahani A; Luciani DS; Johnson JD; Rodrigues B
    Cardiovasc Res; 2009 Oct; 84(1):42-53. PubMed ID: 19477967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.